Plump Andrew Stewartinsider trades

In SEC Form 4 filings, Plump Andrew Stewart is listed as President, R&D of Takeda Pharmaceutical Co Ltd (TAK). In the last 90 days, Plump Andrew Stewart sold $2.51M of Takeda Pharmaceutical Co Ltd (TAK) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
TAKTakeda Pharmaceutical Co Ltd	President, R&D	2	Sep 3

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-21

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
TAKTakeda Pharmaceutical Co Ltd	Sep 2	Sep 3	S	116,191	$18.49	Sale −$2,148,372	145,465	Yes	Form 4
TAKTakeda Pharmaceutical Co Ltd	Aug 19	Aug 21	S	19,651	$18.49	Sale −$363,347	261,656	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.